Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Cost of Care

The ASCO Post Staff

Clifford A. Hudis, MD, and Allen S. Lichter, MD, on Oncology Drug Pricing in the United States: What You Need to Know

Allen S. Lichter, MD, of the Value in Cancer Care Consortium, interviews Clifford A. Hudis, MD, Chief Executive Officer of ASCO, on the question of whether cancer drug prices in the United States are the problem, or just the symptom, of a larger systemic issue.

Opportunities to Optimize Cancer Policies Panel Discussion

Welcome and Introduction to Vi3C

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement




Nov
18
Today In Oncology
My 50 Years in Lymphoma: Lessons Learned?
Does Kidney Stone History Impact Survival Outcomes in Upper Tract Urothelial Carcinoma
Active Surveillance With Metformin vs Placebo in Low-Risk Prostate Cancer
Izalontamab Brengitecan in Recurrent or Metastatic Nasopharyngeal Carcinoma
FDA Approves Epcoritamab for Two Follicular Lymphoma Indications
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo